Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension

Thorax

Volumn 60, Issue 9, 2005, Pages 765-772

  Tamby, M C ^a,b   Chanseaud, Y ^a,b   Humbert, M ^c   Fermanian, J ^d   Guilpain, P ^a,b   Garcia De La Pena Lefebvre P ^b   Brunet, S ^b   Servettaz, A ^a   Weill, B ^a   Simonneau, G ^c   Guillevin, L ^e   Boissier, M C ^b   Mouthon, L ^a,b,e  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e AP HP et Université Paris V ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL ANTIGEN; CELL EXTRACT; CENTROMERE ANTIBODY; DNA TOPOISOMERASE ANTIBODY; ENDOTHELIAL CELL ANTIBODY; ENZYME ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING ASSAY; CELL ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; HEART CATHETERIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREACTIVITY; LUNG ARTERY PRESSURE; LUNG ENDOTHELIUM; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SKIN CELL; SYSTEMIC SCLEROSIS;

ADULT; ANTIGENS; AUTOANTIBODIES; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; SCLERODERMA, SYSTEMIC; UMBILICAL VEINS;

EID: 24744455197     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.029082     Document Type: Article

References (28)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-7.
2. Dorfmuller P, Perros F, Balabanian K, et al. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-63.
3. Mukerjee D, St George D, Coleiro B, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
4. Lane KB, Machado RD, Pauciulo MW, et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000;26:81-4.
5. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
6. Morse J, Barst R, Horn E, et al. Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 2002;29:2379-81.
7. Rosenbaum J, Pottinger BE, Woo P, et al. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988;72:450-6.
8. Hill MB, Phipps JL, Cartwright RJ, et al. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996;106:491-7.
9. Salojin KV, Le Tonqueze M, Saraux A, et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med 1997;102:178-85.
10. Negi VS, Tripathy NK, Misra R, et al. Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 1998;25:462-6.
11. Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, et al. IgG reactivity with a 100-kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited and diffuse systemic sclerosis patients. Clin Immunol 2004;111:241-51.
12. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
13. Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
14. Chanseaud Y, Pena-Lefebvre PG, Guilpain P, et al. IgM and IgG autoantibodies from microscopic polyangiitis patients out not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens. Clin Immunol 2003;109:165-78.
15. Harman HH. Modern factor analysis, 2nd edn. Chicago: The University Of Chicago Press, 1967.
16. Voelkel N, Tuder R, Weir E. Pathophysiology of primary pulmonary hypertension from physiology to molecular mechanisms. In: Rubin L, Rich S, eds. Primary pulmonary hypertension. New York: Marcel Dekker, 1997:83-129.
17. Ihn H, Sato S, Fujimoto M, et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 2000;119:203-9.
18. Praprotnik S, Blank M, Meroni PL, et al. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001;44:1484-94.
19. Direskeneli H, D'Cruz D, Khamashta MA, et al. Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. Clin Immunol Immunopathol 1994;70:206-10.
20. Chan TM, Frampton G, Staines NA, et al. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol 1992;88:68-74.
21. Del Papa N, Sheng YH, Raschi E, et al. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. J Immunol 1998;160:5572-8.
22. Savage CO, Gaskin G, Pusey CD, et al. Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens. Exp Nephrol 1993;1:190-5.
23. de Bandt M, Benali K, Guillevin L, et al. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study. J Rheumatol 1999;26:91-6.
24. Lee KH, Chung HS, Kim HS, et al. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease. Arthritis Rheum 2003;48:2025-35.
25. Okawa-Takatsuji M, Aotsuka S, Fujinami M, et al. Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein. Clin Exp Immunol 1999;116:174-80.
26. Sgonc R, Gruschwitz M, Boeck G, et al. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000;43:2550-62.
27. Bruneel A, Labas V, Mailloux A, et al. Proteomic study of human umbilical vein endothelial cells in culture. Proteomics 2003;3:714-23.
28. Mouthon L, Nobrega A, Nicolas N, et al. Invariance and restriction towards a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sc USA 1995;92:3839-43.